{"id":12648,"date":"2025-06-19T07:08:00","date_gmt":"2025-06-19T07:08:00","guid":{"rendered":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/"},"modified":"2025-06-19T07:08:00","modified_gmt":"2025-06-19T07:08:00","slug":"%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91","status":"publish","type":"post","link":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/","title":{"rendered":"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee"},"content":{"rendered":"<p><span class=\"legendSpanClass\">\u5317\u4eac<\/span><span class=\"legendSpanClass\">2025\u5e746\u670819\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; 2025\u5e74\u7b2c30\u5c4a\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\u5e74\u4f1a\uff08EHA 2025\uff09\u4e8e6\u670812\u65e5~15\u65e5\u5728\u610f\u5927\u5229\u7c73\u5170\u76db\u5927\u53ec\u5f00\u3002\u4f5c\u4e3a\u6b27\u6d32\u8840\u6db2\u5b66\u9886\u57df\u89c4\u6a21\u6700\u5927\u7684\u5b66\u672f\u76db\u5bb4\uff0c\u5927\u4f1a\u6bcf\u5e74\u90fd\u5438\u5f15\u7740\u6765\u81ea\u5168\u7403100\u591a\u4e2a\u56fd\u5bb6\u7684<span>\u77e5\u540d<\/span>\u8840\u6db2\u5b66\u4e13\u5bb6\u53c2\u4f1a\uff0c\u672c\u5c4a\u5927\u4f1a\u4ee5&#8221;\u52a0\u901f\u8840\u6db2\u5b66\u521b\u65b0\u8f6c\u5316&#8221;\u4e3a\u4e3b\u9898\uff0c\u5438\u5f15\u5168\u7403\u903e\u4e07\u540d\u5b66\u8005\u53c2\u4e0e\u3002<\/p>\n<p>\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f8\u9879\u524d\u6cbf\u7814\u7a76\u6210\u679c\u518d\u5ea6\u4eae\u76f8\uff0c\u5185\u5bb9\u6db5\u76d6CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u4f18\u5316\u3001\u7f55\u89c1\u767d\u8840\u75c5\u5206\u5b50\u673a\u5236\u7b49\u70ed\u70b9\u9886\u57df\u3002\u5176\u4e2d\uff0c\u9646\u9053\u57f9\u533b\u9662\u533b\u7597\u6267\u884c\u9662\u957f\u3001\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u7684\u53e3\u5934\u62a5\u544a\uff08oral\uff09\u4ee5\u7a81\u7834\u6027\u901a\u7528\u578bCAR-T\u6280\u672f\u4e34\u5e8a\u5b9e\u8df5\u6210\u679c\u5f15\u53d1\u5728\u573a\u4e13\u5bb6\u5b66\u8005\u7684\u5e7f\u6cdb\u5173\u6ce8\uff0c7\u9879\u5899\u62a5\u5c55\u793a\uff08Poster\uff09\u5219\u51f8\u663e\u56e2\u961f\u591a\u7ef4\u5ea6\u79d1\u7814\u5b9e\u529b\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnewswire.com\/media\/2713766\/image_1.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<\/div>\n<p>\u5f53\u5730\u65f6\u95f411:45\uff0c\u9646\u4f69\u534e\u9662\u957f\u53e3\u5934\u62a5\u544a\u4e86\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\uff0c\u62a5\u544a\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients With Relapsed or Refractory (R\/R) T-cell Acute Lymphoblastic Leukemia \/ Lymphoblastic Lymphoma (T-ALL\/LBL)\uff3bCTD402\uff1a\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\u6216\u96be\u6cbb\u6027\uff08R\/R\uff09T \u7ec6\u80de\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u6dcb\u5df4\u6bcd\u7ec6\u80de\u6dcb\u5df4\u7624\uff08T-ALL\/LBL\uff09\u60a3\u8005\u7684\u901a\u7528\u578b\u6297 CD7 \u5d4c\u5408\u6297\u539f\u53d7\u4f53T\u7ec6\u80de\u7597\u6cd5\uff0c\u6458\u8981\u53f7\uff1aS283\uff3d\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnewswire.com\/media\/2713767\/image_2.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<\/div>\n<p>\u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u9488\u5bf9R\/R T-ALL\/LBL\u60a3\u8005\u751f\u5b58\u7387\u6781\u4f4e\uff085\u5e74OS\u7387\uff1c20%\uff09\u4e14\u7f3a\u4e4f\u6709\u6548\u7597\u6cd5\u7684\u4e34\u5e8a\u56f0\u5883\uff0cCTD402\u901a\u8fc7\u4e09\u91cd\u57fa\u56e0\u7f16\u8f91\uff08\u6572\u9664TCR\u3001CD7\u53caHLA-II\u7c7b\u5206\u5b50\uff09\uff0c\u6210\u529f\u89e3\u51b3\u4e86\u901a\u7528\u578bCAR-T\u7684&#8221;\u81ea\u76f8\u6b8b\u6740&#8221;\u3001\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GvHD\uff09\u53ca\u5bbf\u4e3b\u514d\u75ab\u6392\u65a5\u4e09\u5927\u96be\u9898\u3002\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u7387\u8fbe78%\uff0cCRS\u53d1\u751f\u738779%\u4e1493.9%\u4e3a\u8f7b\u4e2d\u5ea6\uff081-2\u7ea7\uff09\uff0c\u4ec51\u4f8b\u51fa\u73b02\u7ea7GvHD\uff0c\u8bc1\u5b9e\u5176\u9ad8\u6548\u6027\u4e0e\u53ef\u63a7\u98ce\u9669\uff0c\u4e3a\u65e2\u5f80\u65e0\u836f\u53ef\u6cbb\u7684\u60a3\u8005\u63d0\u4f9b\u4e86\u5e0c\u671b\u3002<\/p>\n<p>\u9646\u4f69\u534e\u9662\u957f\u6f14\u8bb2\u7ed3\u675f\u540e\uff0c\u73b0\u573a\u53cd\u54cd\u70ed\u70c8\uff0c\u591a\u4f4d\u56fd\u9645\u5b66\u8005\u5c31\u56de\u8f93\u540e\u514d\u75ab\u91cd\u5efa\u3001\u4f9b\u4f53\u9009\u62e9\u4e0e\u5236\u5907\u6548\u7387\u3001\u6700\u4f73\u79fb\u690d\u6865\u63a5\u65f6\u673a\u7b49\u4e34\u5e8a\u5173\u6ce8\u7126\u70b9\u95ee\u9898\u8fdb\u884c\u63d0\u95ee\u4ea4\u6d41\uff0c\u8ba4\u4e3a\u6b64\u7814\u7a76\u6709\u671b\u4e3a\u4e34\u5e8a\u8fdb\u4e00\u6b65\u8f6c\u5316\u5960\u5b9a\u57fa\u7840\u3002\u672c\u73af\u8282\u4e3b\u5e2d\uff0c\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u9886\u57df\u6743\u5a01\u4e13\u5bb6\u3001\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66Marco Ruella\u6559\u6388\u4e3b\u52a8\u4e0e\u9646\u4f69\u534e\u9662\u957f\u5408\u5f71\uff0c\u5e76\u9ad8\u5ea6\u8bc4\u4ef7\u8be5\u9879\u7814\u7a76\u3002\u53e6\u4e00\u4f4d\u4e3b\u5e2d\u3001\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u5927\u5b66Nuria Martinez-Cibrian\u6559\u6388\uff0c\u4ea6\u5bf9\u9646\u4f69\u534e\u9662\u957f\u7684\u62a5\u544a\u8868\u73b0\u51fa\u6d53\u539a\u5174\u8da3\uff0c\u4f1a\u540e\u4e0e\u591a\u4f4d\u4e0e\u4f1a\u5b66\u8005\u8ffd\u8be2\u7814\u7a76\u7ec6\u8282\uff0c\u5e76\u5c31\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnewswire.com\/media\/2713768\/image_3.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<\/div>\n<p>\u6b64\u5916\uff0c\u56e2\u961f\u76847\u9879\u5899\u62a5\u5c55\u793a\u805a\u7126CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u3001\u5206\u5b50\u673a\u5236\u7814\u7a76\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u540c\u6837\u5438\u5f15\u5927\u6279\u4e34\u5e8a\u4e13\u5bb6\u5b66\u8005\u9a7b\u8db3\u4ea4\u6d41\u3002\u672c\u5c4a\u5927\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u5165\u9009\u76848\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u4ece\u9776\u70b9\u673a\u5236\u89e3\u5bc6\u5230\u4e34\u5e8a\u8def\u5f84\u4f18\u5316\u7684\u5168\u94fe\u6761\u521b\u65b0\uff0c\u5f70\u663e\u4e2d\u56fd\u5b66\u8005\u5728\u8840\u6db2\u80bf\u7624\u9886\u57df\u7684\u521b\u65b0\u9886\u5bfc\u529b\uff0c\u7d2f\u8ba1\u8d851.15\u4e07\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\uff08\u4eb2\u7f18\u534a\u76f8\u5408\u5360\u6bd4\u8d8570%\uff09\u53ca\u903e2500\u4f8bCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u5e9e\u5927\u4e34\u5e8a\u89c4\u6a21\uff0c\u7a33\u5c45\u5168\u7403\u8840\u6db2\u75c5\u5355\u4e2d\u5fc3\u524d\u5217\uff0c\u8fd9\u4e00\u72ec\u4e00\u65e0\u4e8c\u7684&#8221;\u9053\u57f9\u6570\u636e\u6c60&#8221;\uff0c\u4e3a\u56e2\u961f\u7a81\u7834\u6027\u7684\u7814\u7a76\u63d0\u4f9b\u4e86\u575a\u5b9e\u652f\u6491\u3002<\/p>\n<p>\u591a\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u575a\u6301\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u4ece\u4e34\u5e8a\u5b9e\u9645\u51fa\u53d1\uff0c\u805a\u7126\u8840\u6db2\u80bf\u7624\u60a3\u8005\u9700\u6c42\uff0c\u6784\u5efa\u4e86\u4ece\u7cbe\u51c6\u5206\u5c42\uff0c\u4e2a\u4f53\u5316\u6cbb\u7597\u5230\u5168\u7a0b\u7ba1\u7406\u7684\u7cbe\u51c6\u8bca\u7597\u4f53\u7cfb\u3002\u672a\u6765\uff0c\u5176\u5c06\u7ee7\u7eed\u901a\u8fc7\u4e0d\u65ad\u5730\u521b\u65b0\u548c\u52aa\u529b\uff0c\u63d0\u5347\u8bca\u7597\u6c34\u5e73\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u5e26\u6765\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u7684\u6cbb\u7597\u65b9\u6848\uff0c\u63a8\u52a8\u4e2d\u56fd\u8840\u6db2\u75c5\u4e8b\u4e1a\u7684\u6301\u7eed\u53d1\u5c55\u3002<\/p>\n<p>\u9646\u9053\u57f9\u533b\u7597\u56e2\u961fEHA2025 \u6210\u679c\u4e00\u89c8<\/p>\n<p>\u53e3\u5934\u62a5\u544a<br \/>\u6458\u8981\u53f7\uff1aS283<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9646\u4f69\u534e\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u4efb\u6c5f\u6d9b<br \/>\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients With Relapsed or Refractory (R\/R) T-cell Acute Lymphoblastic Leukemia \/ Lymphoblastic Lymphoma (T-ALL\/LBL)<\/p>\n<p>\u5899\u62a5\u5c55\u793a<br \/>\u6458\u8981\u53f7\uff1aPF392<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5362\u5cb3\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5362\u5cb3<br \/>\u9898\u76ee\uff1aComparison of Different Doses of Rabbit Anti-Thymocyte Globulin (ATG-T) and Anti-T-lymphocyte Globulin (ATLG) in TBI-Based Myeloablative Conditioning for Haploidentical Transplantation in Acute Lymphoblastic Leukemia Patients<\/p>\n<p>\u6458\u8981\u53f7\uff1aPF457<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5468\u6653\u82cf\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aEpidemiology, Clinical Features, and Molecular Basis of TTMV::RARA driven Acute Promyelocytic Leukemia<\/p>\n<p>\u6458\u8981\u53f7\uff1aPF948<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u5f26\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5f20\u5f26<br \/>\u9898\u76ee\uff1aSingle center analysis of autologous hematopoietic stem cell transplantation followed by CD19\/CD22 CART for the treatment of refractory and relapsed highly aggressive B-cell lymphoma<\/p>\n<p>\u6458\u8981\u53f7\uff1aPF1044<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u4f55\u6d77\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5b59\u745e\u5a1f<br \/>\u9898\u76ee\uff1aOutcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With NUP98-Rearranged Acute Myeloid Leukaemia: A Single-Center Large-Sample Cohort Study<\/p>\n<p>\u6458\u8981\u53f7\uff1aPS1388<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u738b\u5f64\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u738b\u5f64<br \/>\u9898\u76ee\uff1aGenetic Characteristics of BCR::ABL1-Positive B-Acute Lymphoblastic Leukemia with Multi-Lineage Involvement and Survival Analysis after allo-HSCT<\/p>\n<p>\u6458\u8981\u53f7\uff1aPS2039<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u94ed\u6960\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5b59\u745e\u5a1f<br \/>\u9898\u76ee\uff1aEfficacy Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in 140 Pediatric Patients with KMT2A Rearrangements Acute Myeloid Leukemia<\/p>\n<p>\u6458\u8981\u53f7\uff1aPS2083<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9a6c\u8587\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u66f9\u661f\u7389<br \/>\u9898\u76ee\uff1aSingle-Center Retrospective Analysis of the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation for MLL::AF6 Fusion Gene Positive Acute Myeloid Leukemia<\/p>\n<p>\u6ce8\uff1a\u4e0a\u8ff0\u7814\u7a76\u6210\u679c\u6309\u6458\u8981\u53f7\u6392\u5e8f<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>\n<p>SOURCE  \u9646\u9053\u57f9\u533b\u7597\u96c6\u56e2<\/p>","protected":false},"excerpt":{"rendered":"<p>\u5317\u4eac2025\u5e746\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2025\u5e74\u7b2c30\u5c4a\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\u5e74\u4f1a\uff08EHA 2025\uff09\u4e8e6\u670812\u65e5~15\u65e5\u5728\u610f\u5927\u5229\u7c73\u5170\u76db\u5927\u53ec\u5f00\u3002\u4f5c\u4e3a\u6b27\u6d32\u8840\u6db2\u5b66\u9886\u57df\u89c4\u6a21\u6700\u5927\u7684\u5b66\u672f\u76db\u5bb4\uff0c\u5927\u4f1a\u6bcf\u5e74\u90fd\u5438\u5f15\u7740\u6765\u81ea\u5168\u7403100\u591a\u4e2a\u56fd\u5bb6\u7684\u77e5\u540d\u8840\u6db2\u5b66\u4e13\u5bb6\u53c2\u4f1a\uff0c\u672c\u5c4a\u5927\u4f1a\u4ee5&#8221;\u52a0\u901f\u8840\u6db2\u5b66\u521b\u65b0\u8f6c\u5316&#8221;\u4e3a\u4e3b\u9898\uff0c\u5438\u5f15\u5168\u7403\u903e\u4e07\u540d\u5b66\u8005\u53c2\u4e0e\u3002 \u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f8\u9879\u524d\u6cbf\u7814\u7a76\u6210\u679c\u518d\u5ea6\u4eae\u76f8\uff0c\u5185\u5bb9\u6db5\u76d6CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u4f18\u5316\u3001\u7f55\u89c1\u767d\u8840\u75c5\u5206\u5b50\u673a\u5236\u7b49\u70ed\u70b9\u9886\u57df\u3002\u5176\u4e2d\uff0c\u9646\u9053\u57f9\u533b\u9662\u533b\u7597\u6267\u884c\u9662\u957f\u3001\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u7684\u53e3\u5934\u62a5\u544a\uff08oral\uff09\u4ee5\u7a81\u7834\u6027\u901a\u7528\u578bCAR-T\u6280\u672f\u4e34\u5e8a\u5b9e\u8df5\u6210\u679c\u5f15\u53d1\u5728\u573a\u4e13\u5bb6\u5b66\u8005\u7684\u5e7f\u6cdb\u5173\u6ce8\uff0c7\u9879\u5899\u62a5\u5c55\u793a\uff08Poster\uff09\u5219\u51f8\u663e\u56e2\u961f\u591a\u7ef4\u5ea6\u79d1\u7814\u5b9e\u529b\u3002 \u5f53\u5730\u65f6\u95f411:45\uff0c\u9646\u4f69\u534e\u9662\u957f\u53e3\u5934\u62a5\u544a\u4e86\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\uff0c\u62a5\u544a\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients With Relapsed or Refractory (R\/R) T-cell Acute Lymphoblastic Leukemia \/ Lymphoblastic Lymphoma (T-ALL\/LBL)\uff3bCTD402\uff1a\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\u6216\u96be\u6cbb\u6027\uff08R\/R\uff09T \u7ec6\u80de\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u6dcb\u5df4\u6bcd\u7ec6\u80de\u6dcb\u5df4\u7624\uff08T-ALL\/LBL\uff09\u60a3\u8005\u7684\u901a\u7528\u578b\u6297 CD7 \u5d4c\u5408\u6297\u539f\u53d7\u4f53T\u7ec6\u80de\u7597\u6cd5\uff0c\u6458\u8981\u53f7\uff1aS283\uff3d\u3002 \u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u9488\u5bf9R\/R T-ALL\/LBL\u60a3\u8005\u751f\u5b58\u7387\u6781\u4f4e\uff085\u5e74OS\u7387\uff1c20%\uff09\u4e14\u7f3a\u4e4f\u6709\u6548\u7597\u6cd5\u7684\u4e34\u5e8a\u56f0\u5883\uff0cCTD402\u901a\u8fc7\u4e09\u91cd\u57fa\u56e0\u7f16\u8f91\uff08\u6572\u9664TCR\u3001CD7\u53caHLA-II\u7c7b\u5206\u5b50\uff09\uff0c\u6210\u529f\u89e3\u51b3\u4e86\u901a\u7528\u578bCAR-T\u7684&#8221;\u81ea\u76f8\u6b8b\u6740&#8221;\u3001\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GvHD\uff09\u53ca\u5bbf\u4e3b\u514d\u75ab\u6392\u65a5\u4e09\u5927\u96be\u9898\u3002\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u7387\u8fbe78%\uff0cCRS\u53d1\u751f\u738779%\u4e1493.9%\u4e3a\u8f7b\u4e2d\u5ea6\uff081-2\u7ea7\uff09\uff0c\u4ec51\u4f8b\u51fa\u73b02\u7ea7GvHD\uff0c\u8bc1\u5b9e\u5176\u9ad8\u6548\u6027\u4e0e\u53ef\u63a7\u98ce\u9669\uff0c\u4e3a\u65e2\u5f80\u65e0\u836f\u53ef\u6cbb\u7684\u60a3\u8005\u63d0\u4f9b\u4e86\u5e0c\u671b\u3002 \u9646\u4f69\u534e\u9662\u957f\u6f14\u8bb2\u7ed3\u675f\u540e\uff0c\u73b0\u573a\u53cd\u54cd\u70ed\u70c8\uff0c\u591a\u4f4d\u56fd\u9645\u5b66\u8005\u5c31\u56de\u8f93\u540e\u514d\u75ab\u91cd\u5efa\u3001\u4f9b\u4f53\u9009\u62e9\u4e0e\u5236\u5907\u6548\u7387\u3001\u6700\u4f73\u79fb\u690d\u6865\u63a5\u65f6\u673a\u7b49\u4e34\u5e8a\u5173\u6ce8\u7126\u70b9\u95ee\u9898\u8fdb\u884c\u63d0\u95ee\u4ea4\u6d41\uff0c\u8ba4\u4e3a\u6b64\u7814\u7a76\u6709\u671b\u4e3a\u4e34\u5e8a\u8fdb\u4e00\u6b65\u8f6c\u5316\u5960\u5b9a\u57fa\u7840\u3002\u672c\u73af\u8282\u4e3b\u5e2d\uff0c\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u9886\u57df\u6743\u5a01\u4e13\u5bb6\u3001\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66Marco Ruella\u6559\u6388\u4e3b\u52a8\u4e0e\u9646\u4f69\u534e\u9662\u957f\u5408\u5f71\uff0c\u5e76\u9ad8\u5ea6\u8bc4\u4ef7\u8be5\u9879\u7814\u7a76\u3002\u53e6\u4e00\u4f4d\u4e3b\u5e2d\u3001\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u5927\u5b66Nuria Martinez-Cibrian\u6559\u6388\uff0c\u4ea6\u5bf9\u9646\u4f69\u534e\u9662\u957f\u7684\u62a5\u544a\u8868\u73b0\u51fa\u6d53\u539a\u5174\u8da3\uff0c\u4f1a\u540e\u4e0e\u591a\u4f4d\u4e0e\u4f1a\u5b66\u8005\u8ffd\u8be2\u7814\u7a76\u7ec6\u8282\uff0c\u5e76\u5c31\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u6b64\u5916\uff0c\u56e2\u961f\u76847\u9879\u5899\u62a5\u5c55\u793a\u805a\u7126CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u3001\u5206\u5b50\u673a\u5236\u7814\u7a76\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u540c\u6837\u5438\u5f15\u5927\u6279\u4e34\u5e8a\u4e13\u5bb6\u5b66\u8005\u9a7b\u8db3\u4ea4\u6d41\u3002\u672c\u5c4a\u5927\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u5165\u9009\u76848\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u4ece\u9776\u70b9\u673a\u5236\u89e3\u5bc6\u5230\u4e34\u5e8a\u8def\u5f84\u4f18\u5316\u7684\u5168\u94fe\u6761\u521b\u65b0\uff0c\u5f70\u663e\u4e2d\u56fd\u5b66\u8005\u5728\u8840\u6db2\u80bf\u7624\u9886\u57df\u7684\u521b\u65b0\u9886\u5bfc\u529b\uff0c\u7d2f\u8ba1\u8d851.15\u4e07\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\uff08\u4eb2\u7f18\u534a\u76f8\u5408\u5360\u6bd4\u8d8570%\uff09\u53ca\u903e2500\u4f8bCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u5e9e\u5927\u4e34\u5e8a\u89c4\u6a21\uff0c\u7a33\u5c45\u5168\u7403\u8840\u6db2\u75c5\u5355\u4e2d\u5fc3\u524d\u5217\uff0c\u8fd9\u4e00\u72ec\u4e00\u65e0\u4e8c\u7684&#8221;\u9053\u57f9\u6570\u636e\u6c60&#8221;\uff0c\u4e3a\u56e2\u961f\u7a81\u7834\u6027\u7684\u7814\u7a76\u63d0\u4f9b\u4e86\u575a\u5b9e\u652f\u6491\u3002 \u591a\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u575a\u6301\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u4ece\u4e34\u5e8a\u5b9e\u9645\u51fa\u53d1\uff0c\u805a\u7126\u8840\u6db2\u80bf\u7624\u60a3\u8005\u9700\u6c42\uff0c\u6784\u5efa\u4e86\u4ece\u7cbe\u51c6\u5206\u5c42\uff0c\u4e2a\u4f53\u5316\u6cbb\u7597\u5230\u5168\u7a0b\u7ba1\u7406\u7684\u7cbe\u51c6\u8bca\u7597\u4f53\u7cfb\u3002\u672a\u6765\uff0c\u5176\u5c06\u7ee7\u7eed\u901a\u8fc7\u4e0d\u65ad\u5730\u521b\u65b0\u548c\u52aa\u529b\uff0c\u63d0\u5347\u8bca\u7597\u6c34\u5e73\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u5e26\u6765\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u7684\u6cbb\u7597\u65b9\u6848\uff0c\u63a8\u52a8\u4e2d\u56fd\u8840\u6db2\u75c5\u4e8b\u4e1a\u7684\u6301\u7eed\u53d1\u5c55\u3002 \u9646\u9053\u57f9\u533b\u7597\u56e2\u961fEHA2025 \u6210\u679c\u4e00\u89c8 \u53e3\u5934\u62a5\u544a\u6458\u8981\u53f7\uff1aS283\u7b2c\u4e00\u4f5c\u8005\uff1a\u9646\u4f69\u534e\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u4efb\u6c5f\u6d9b\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":12649,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-12648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/moneycompass.com.my\/cn\/\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025eha\uff0c\u901a\u7528\u578bcar-t\u7597\u6cd5\u5f15\u53d1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN\" \/>\n<meta property=\"og:description\" content=\"\u5317\u4eac2025\u5e746\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2025\u5e74\u7b2c30\u5c4a\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\u5e74\u4f1a\uff08EHA 2025\uff09\u4e8e6\u670812\u65e5~15\u65e5\u5728\u610f\u5927\u5229\u7c73\u5170\u76db\u5927\u53ec\u5f00\u3002\u4f5c\u4e3a\u6b27\u6d32\u8840\u6db2\u5b66\u9886\u57df\u89c4\u6a21\u6700\u5927\u7684\u5b66\u672f\u76db\u5bb4\uff0c\u5927\u4f1a\u6bcf\u5e74\u90fd\u5438\u5f15\u7740\u6765\u81ea\u5168\u7403100\u591a\u4e2a\u56fd\u5bb6\u7684\u77e5\u540d\u8840\u6db2\u5b66\u4e13\u5bb6\u53c2\u4f1a\uff0c\u672c\u5c4a\u5927\u4f1a\u4ee5&#8221;\u52a0\u901f\u8840\u6db2\u5b66\u521b\u65b0\u8f6c\u5316&#8221;\u4e3a\u4e3b\u9898\uff0c\u5438\u5f15\u5168\u7403\u903e\u4e07\u540d\u5b66\u8005\u53c2\u4e0e\u3002 \u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f8\u9879\u524d\u6cbf\u7814\u7a76\u6210\u679c\u518d\u5ea6\u4eae\u76f8\uff0c\u5185\u5bb9\u6db5\u76d6CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u4f18\u5316\u3001\u7f55\u89c1\u767d\u8840\u75c5\u5206\u5b50\u673a\u5236\u7b49\u70ed\u70b9\u9886\u57df\u3002\u5176\u4e2d\uff0c\u9646\u9053\u57f9\u533b\u9662\u533b\u7597\u6267\u884c\u9662\u957f\u3001\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u7684\u53e3\u5934\u62a5\u544a\uff08oral\uff09\u4ee5\u7a81\u7834\u6027\u901a\u7528\u578bCAR-T\u6280\u672f\u4e34\u5e8a\u5b9e\u8df5\u6210\u679c\u5f15\u53d1\u5728\u573a\u4e13\u5bb6\u5b66\u8005\u7684\u5e7f\u6cdb\u5173\u6ce8\uff0c7\u9879\u5899\u62a5\u5c55\u793a\uff08Poster\uff09\u5219\u51f8\u663e\u56e2\u961f\u591a\u7ef4\u5ea6\u79d1\u7814\u5b9e\u529b\u3002 \u5f53\u5730\u65f6\u95f411:45\uff0c\u9646\u4f69\u534e\u9662\u957f\u53e3\u5934\u62a5\u544a\u4e86\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\uff0c\u62a5\u544a\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients With Relapsed or Refractory (R\/R) T-cell Acute Lymphoblastic Leukemia \/ Lymphoblastic Lymphoma (T-ALL\/LBL)\uff3bCTD402\uff1a\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\u6216\u96be\u6cbb\u6027\uff08R\/R\uff09T \u7ec6\u80de\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u6dcb\u5df4\u6bcd\u7ec6\u80de\u6dcb\u5df4\u7624\uff08T-ALL\/LBL\uff09\u60a3\u8005\u7684\u901a\u7528\u578b\u6297 CD7 \u5d4c\u5408\u6297\u539f\u53d7\u4f53T\u7ec6\u80de\u7597\u6cd5\uff0c\u6458\u8981\u53f7\uff1aS283\uff3d\u3002 \u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u9488\u5bf9R\/R T-ALL\/LBL\u60a3\u8005\u751f\u5b58\u7387\u6781\u4f4e\uff085\u5e74OS\u7387\uff1c20%\uff09\u4e14\u7f3a\u4e4f\u6709\u6548\u7597\u6cd5\u7684\u4e34\u5e8a\u56f0\u5883\uff0cCTD402\u901a\u8fc7\u4e09\u91cd\u57fa\u56e0\u7f16\u8f91\uff08\u6572\u9664TCR\u3001CD7\u53caHLA-II\u7c7b\u5206\u5b50\uff09\uff0c\u6210\u529f\u89e3\u51b3\u4e86\u901a\u7528\u578bCAR-T\u7684&#8221;\u81ea\u76f8\u6b8b\u6740&#8221;\u3001\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GvHD\uff09\u53ca\u5bbf\u4e3b\u514d\u75ab\u6392\u65a5\u4e09\u5927\u96be\u9898\u3002\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u7387\u8fbe78%\uff0cCRS\u53d1\u751f\u738779%\u4e1493.9%\u4e3a\u8f7b\u4e2d\u5ea6\uff081-2\u7ea7\uff09\uff0c\u4ec51\u4f8b\u51fa\u73b02\u7ea7GvHD\uff0c\u8bc1\u5b9e\u5176\u9ad8\u6548\u6027\u4e0e\u53ef\u63a7\u98ce\u9669\uff0c\u4e3a\u65e2\u5f80\u65e0\u836f\u53ef\u6cbb\u7684\u60a3\u8005\u63d0\u4f9b\u4e86\u5e0c\u671b\u3002 \u9646\u4f69\u534e\u9662\u957f\u6f14\u8bb2\u7ed3\u675f\u540e\uff0c\u73b0\u573a\u53cd\u54cd\u70ed\u70c8\uff0c\u591a\u4f4d\u56fd\u9645\u5b66\u8005\u5c31\u56de\u8f93\u540e\u514d\u75ab\u91cd\u5efa\u3001\u4f9b\u4f53\u9009\u62e9\u4e0e\u5236\u5907\u6548\u7387\u3001\u6700\u4f73\u79fb\u690d\u6865\u63a5\u65f6\u673a\u7b49\u4e34\u5e8a\u5173\u6ce8\u7126\u70b9\u95ee\u9898\u8fdb\u884c\u63d0\u95ee\u4ea4\u6d41\uff0c\u8ba4\u4e3a\u6b64\u7814\u7a76\u6709\u671b\u4e3a\u4e34\u5e8a\u8fdb\u4e00\u6b65\u8f6c\u5316\u5960\u5b9a\u57fa\u7840\u3002\u672c\u73af\u8282\u4e3b\u5e2d\uff0c\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u9886\u57df\u6743\u5a01\u4e13\u5bb6\u3001\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66Marco Ruella\u6559\u6388\u4e3b\u52a8\u4e0e\u9646\u4f69\u534e\u9662\u957f\u5408\u5f71\uff0c\u5e76\u9ad8\u5ea6\u8bc4\u4ef7\u8be5\u9879\u7814\u7a76\u3002\u53e6\u4e00\u4f4d\u4e3b\u5e2d\u3001\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u5927\u5b66Nuria Martinez-Cibrian\u6559\u6388\uff0c\u4ea6\u5bf9\u9646\u4f69\u534e\u9662\u957f\u7684\u62a5\u544a\u8868\u73b0\u51fa\u6d53\u539a\u5174\u8da3\uff0c\u4f1a\u540e\u4e0e\u591a\u4f4d\u4e0e\u4f1a\u5b66\u8005\u8ffd\u8be2\u7814\u7a76\u7ec6\u8282\uff0c\u5e76\u5c31\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u6b64\u5916\uff0c\u56e2\u961f\u76847\u9879\u5899\u62a5\u5c55\u793a\u805a\u7126CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u3001\u5206\u5b50\u673a\u5236\u7814\u7a76\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u540c\u6837\u5438\u5f15\u5927\u6279\u4e34\u5e8a\u4e13\u5bb6\u5b66\u8005\u9a7b\u8db3\u4ea4\u6d41\u3002\u672c\u5c4a\u5927\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u5165\u9009\u76848\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u4ece\u9776\u70b9\u673a\u5236\u89e3\u5bc6\u5230\u4e34\u5e8a\u8def\u5f84\u4f18\u5316\u7684\u5168\u94fe\u6761\u521b\u65b0\uff0c\u5f70\u663e\u4e2d\u56fd\u5b66\u8005\u5728\u8840\u6db2\u80bf\u7624\u9886\u57df\u7684\u521b\u65b0\u9886\u5bfc\u529b\uff0c\u7d2f\u8ba1\u8d851.15\u4e07\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\uff08\u4eb2\u7f18\u534a\u76f8\u5408\u5360\u6bd4\u8d8570%\uff09\u53ca\u903e2500\u4f8bCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u5e9e\u5927\u4e34\u5e8a\u89c4\u6a21\uff0c\u7a33\u5c45\u5168\u7403\u8840\u6db2\u75c5\u5355\u4e2d\u5fc3\u524d\u5217\uff0c\u8fd9\u4e00\u72ec\u4e00\u65e0\u4e8c\u7684&#8221;\u9053\u57f9\u6570\u636e\u6c60&#8221;\uff0c\u4e3a\u56e2\u961f\u7a81\u7834\u6027\u7684\u7814\u7a76\u63d0\u4f9b\u4e86\u575a\u5b9e\u652f\u6491\u3002 \u591a\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u575a\u6301\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u4ece\u4e34\u5e8a\u5b9e\u9645\u51fa\u53d1\uff0c\u805a\u7126\u8840\u6db2\u80bf\u7624\u60a3\u8005\u9700\u6c42\uff0c\u6784\u5efa\u4e86\u4ece\u7cbe\u51c6\u5206\u5c42\uff0c\u4e2a\u4f53\u5316\u6cbb\u7597\u5230\u5168\u7a0b\u7ba1\u7406\u7684\u7cbe\u51c6\u8bca\u7597\u4f53\u7cfb\u3002\u672a\u6765\uff0c\u5176\u5c06\u7ee7\u7eed\u901a\u8fc7\u4e0d\u65ad\u5730\u521b\u65b0\u548c\u52aa\u529b\uff0c\u63d0\u5347\u8bca\u7597\u6c34\u5e73\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u5e26\u6765\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u7684\u6cbb\u7597\u65b9\u6848\uff0c\u63a8\u52a8\u4e2d\u56fd\u8840\u6db2\u75c5\u4e8b\u4e1a\u7684\u6301\u7eed\u53d1\u5c55\u3002 \u9646\u9053\u57f9\u533b\u7597\u56e2\u961fEHA2025 \u6210\u679c\u4e00\u89c8 \u53e3\u5934\u62a5\u544a\u6458\u8981\u53f7\uff1aS283\u7b2c\u4e00\u4f5c\u8005\uff1a\u9646\u4f69\u534e\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u4efb\u6c5f\u6d9b\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moneycompass.com.my\/cn\/\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025eha\uff0c\u901a\u7528\u578bcar-t\u7597\u6cd5\u5f15\u53d1\/\" \/>\n<meta property=\"og:site_name\" content=\"Money Compass CN\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-19T07:08:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"144\" \/>\n\t<meta property=\"og:image:height\" content=\"108\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/\",\"name\":\"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN\",\"isPartOf\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg\",\"datePublished\":\"2025-06-19T07:08:00+00:00\",\"dateModified\":\"2025-06-19T07:08:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg\",\"contentUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg\",\"width\":144,\"height\":108},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/moneycompass.com.my\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/\",\"name\":\"Money Compass CN\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/moneycompass.com.my\/cn\/\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025eha\uff0c\u901a\u7528\u578bcar-t\u7597\u6cd5\u5f15\u53d1\/","og_locale":"en_US","og_type":"article","og_title":"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN","og_description":"\u5317\u4eac2025\u5e746\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2025\u5e74\u7b2c30\u5c4a\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\u5e74\u4f1a\uff08EHA 2025\uff09\u4e8e6\u670812\u65e5~15\u65e5\u5728\u610f\u5927\u5229\u7c73\u5170\u76db\u5927\u53ec\u5f00\u3002\u4f5c\u4e3a\u6b27\u6d32\u8840\u6db2\u5b66\u9886\u57df\u89c4\u6a21\u6700\u5927\u7684\u5b66\u672f\u76db\u5bb4\uff0c\u5927\u4f1a\u6bcf\u5e74\u90fd\u5438\u5f15\u7740\u6765\u81ea\u5168\u7403100\u591a\u4e2a\u56fd\u5bb6\u7684\u77e5\u540d\u8840\u6db2\u5b66\u4e13\u5bb6\u53c2\u4f1a\uff0c\u672c\u5c4a\u5927\u4f1a\u4ee5&#8221;\u52a0\u901f\u8840\u6db2\u5b66\u521b\u65b0\u8f6c\u5316&#8221;\u4e3a\u4e3b\u9898\uff0c\u5438\u5f15\u5168\u7403\u903e\u4e07\u540d\u5b66\u8005\u53c2\u4e0e\u3002 \u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f8\u9879\u524d\u6cbf\u7814\u7a76\u6210\u679c\u518d\u5ea6\u4eae\u76f8\uff0c\u5185\u5bb9\u6db5\u76d6CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u4f18\u5316\u3001\u7f55\u89c1\u767d\u8840\u75c5\u5206\u5b50\u673a\u5236\u7b49\u70ed\u70b9\u9886\u57df\u3002\u5176\u4e2d\uff0c\u9646\u9053\u57f9\u533b\u9662\u533b\u7597\u6267\u884c\u9662\u957f\u3001\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u7684\u53e3\u5934\u62a5\u544a\uff08oral\uff09\u4ee5\u7a81\u7834\u6027\u901a\u7528\u578bCAR-T\u6280\u672f\u4e34\u5e8a\u5b9e\u8df5\u6210\u679c\u5f15\u53d1\u5728\u573a\u4e13\u5bb6\u5b66\u8005\u7684\u5e7f\u6cdb\u5173\u6ce8\uff0c7\u9879\u5899\u62a5\u5c55\u793a\uff08Poster\uff09\u5219\u51f8\u663e\u56e2\u961f\u591a\u7ef4\u5ea6\u79d1\u7814\u5b9e\u529b\u3002 \u5f53\u5730\u65f6\u95f411:45\uff0c\u9646\u4f69\u534e\u9662\u957f\u53e3\u5934\u62a5\u544a\u4e86\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\uff0c\u62a5\u544a\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients With Relapsed or Refractory (R\/R) T-cell Acute Lymphoblastic Leukemia \/ Lymphoblastic Lymphoma (T-ALL\/LBL)\uff3bCTD402\uff1a\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\u6216\u96be\u6cbb\u6027\uff08R\/R\uff09T \u7ec6\u80de\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u6dcb\u5df4\u6bcd\u7ec6\u80de\u6dcb\u5df4\u7624\uff08T-ALL\/LBL\uff09\u60a3\u8005\u7684\u901a\u7528\u578b\u6297 CD7 \u5d4c\u5408\u6297\u539f\u53d7\u4f53T\u7ec6\u80de\u7597\u6cd5\uff0c\u6458\u8981\u53f7\uff1aS283\uff3d\u3002 \u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u9488\u5bf9R\/R T-ALL\/LBL\u60a3\u8005\u751f\u5b58\u7387\u6781\u4f4e\uff085\u5e74OS\u7387\uff1c20%\uff09\u4e14\u7f3a\u4e4f\u6709\u6548\u7597\u6cd5\u7684\u4e34\u5e8a\u56f0\u5883\uff0cCTD402\u901a\u8fc7\u4e09\u91cd\u57fa\u56e0\u7f16\u8f91\uff08\u6572\u9664TCR\u3001CD7\u53caHLA-II\u7c7b\u5206\u5b50\uff09\uff0c\u6210\u529f\u89e3\u51b3\u4e86\u901a\u7528\u578bCAR-T\u7684&#8221;\u81ea\u76f8\u6b8b\u6740&#8221;\u3001\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GvHD\uff09\u53ca\u5bbf\u4e3b\u514d\u75ab\u6392\u65a5\u4e09\u5927\u96be\u9898\u3002\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u7387\u8fbe78%\uff0cCRS\u53d1\u751f\u738779%\u4e1493.9%\u4e3a\u8f7b\u4e2d\u5ea6\uff081-2\u7ea7\uff09\uff0c\u4ec51\u4f8b\u51fa\u73b02\u7ea7GvHD\uff0c\u8bc1\u5b9e\u5176\u9ad8\u6548\u6027\u4e0e\u53ef\u63a7\u98ce\u9669\uff0c\u4e3a\u65e2\u5f80\u65e0\u836f\u53ef\u6cbb\u7684\u60a3\u8005\u63d0\u4f9b\u4e86\u5e0c\u671b\u3002 \u9646\u4f69\u534e\u9662\u957f\u6f14\u8bb2\u7ed3\u675f\u540e\uff0c\u73b0\u573a\u53cd\u54cd\u70ed\u70c8\uff0c\u591a\u4f4d\u56fd\u9645\u5b66\u8005\u5c31\u56de\u8f93\u540e\u514d\u75ab\u91cd\u5efa\u3001\u4f9b\u4f53\u9009\u62e9\u4e0e\u5236\u5907\u6548\u7387\u3001\u6700\u4f73\u79fb\u690d\u6865\u63a5\u65f6\u673a\u7b49\u4e34\u5e8a\u5173\u6ce8\u7126\u70b9\u95ee\u9898\u8fdb\u884c\u63d0\u95ee\u4ea4\u6d41\uff0c\u8ba4\u4e3a\u6b64\u7814\u7a76\u6709\u671b\u4e3a\u4e34\u5e8a\u8fdb\u4e00\u6b65\u8f6c\u5316\u5960\u5b9a\u57fa\u7840\u3002\u672c\u73af\u8282\u4e3b\u5e2d\uff0c\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u9886\u57df\u6743\u5a01\u4e13\u5bb6\u3001\u7f8e\u56fd\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66Marco Ruella\u6559\u6388\u4e3b\u52a8\u4e0e\u9646\u4f69\u534e\u9662\u957f\u5408\u5f71\uff0c\u5e76\u9ad8\u5ea6\u8bc4\u4ef7\u8be5\u9879\u7814\u7a76\u3002\u53e6\u4e00\u4f4d\u4e3b\u5e2d\u3001\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u5927\u5b66Nuria Martinez-Cibrian\u6559\u6388\uff0c\u4ea6\u5bf9\u9646\u4f69\u534e\u9662\u957f\u7684\u62a5\u544a\u8868\u73b0\u51fa\u6d53\u539a\u5174\u8da3\uff0c\u4f1a\u540e\u4e0e\u591a\u4f4d\u4e0e\u4f1a\u5b66\u8005\u8ffd\u8be2\u7814\u7a76\u7ec6\u8282\uff0c\u5e76\u5c31\u901a\u7528\u578b\u6297CD7 CAR-T\u7597\u6cd5\u76f8\u5173\u7814\u7a76\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u6b64\u5916\uff0c\u56e2\u961f\u76847\u9879\u5899\u62a5\u5c55\u793a\u805a\u7126CAR-T\u7ec6\u80de\u6cbb\u7597\u3001\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u3001\u5206\u5b50\u673a\u5236\u7814\u7a76\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u540c\u6837\u5438\u5f15\u5927\u6279\u4e34\u5e8a\u4e13\u5bb6\u5b66\u8005\u9a7b\u8db3\u4ea4\u6d41\u3002\u672c\u5c4a\u5927\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u5165\u9009\u76848\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u4ece\u9776\u70b9\u673a\u5236\u89e3\u5bc6\u5230\u4e34\u5e8a\u8def\u5f84\u4f18\u5316\u7684\u5168\u94fe\u6761\u521b\u65b0\uff0c\u5f70\u663e\u4e2d\u56fd\u5b66\u8005\u5728\u8840\u6db2\u80bf\u7624\u9886\u57df\u7684\u521b\u65b0\u9886\u5bfc\u529b\uff0c\u7d2f\u8ba1\u8d851.15\u4e07\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\uff08\u4eb2\u7f18\u534a\u76f8\u5408\u5360\u6bd4\u8d8570%\uff09\u53ca\u903e2500\u4f8bCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u5e9e\u5927\u4e34\u5e8a\u89c4\u6a21\uff0c\u7a33\u5c45\u5168\u7403\u8840\u6db2\u75c5\u5355\u4e2d\u5fc3\u524d\u5217\uff0c\u8fd9\u4e00\u72ec\u4e00\u65e0\u4e8c\u7684&#8221;\u9053\u57f9\u6570\u636e\u6c60&#8221;\uff0c\u4e3a\u56e2\u961f\u7a81\u7834\u6027\u7684\u7814\u7a76\u63d0\u4f9b\u4e86\u575a\u5b9e\u652f\u6491\u3002 \u591a\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u575a\u6301\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u4ece\u4e34\u5e8a\u5b9e\u9645\u51fa\u53d1\uff0c\u805a\u7126\u8840\u6db2\u80bf\u7624\u60a3\u8005\u9700\u6c42\uff0c\u6784\u5efa\u4e86\u4ece\u7cbe\u51c6\u5206\u5c42\uff0c\u4e2a\u4f53\u5316\u6cbb\u7597\u5230\u5168\u7a0b\u7ba1\u7406\u7684\u7cbe\u51c6\u8bca\u7597\u4f53\u7cfb\u3002\u672a\u6765\uff0c\u5176\u5c06\u7ee7\u7eed\u901a\u8fc7\u4e0d\u65ad\u5730\u521b\u65b0\u548c\u52aa\u529b\uff0c\u63d0\u5347\u8bca\u7597\u6c34\u5e73\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u5e26\u6765\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u7684\u6cbb\u7597\u65b9\u6848\uff0c\u63a8\u52a8\u4e2d\u56fd\u8840\u6db2\u75c5\u4e8b\u4e1a\u7684\u6301\u7eed\u53d1\u5c55\u3002 \u9646\u9053\u57f9\u533b\u7597\u56e2\u961fEHA2025 \u6210\u679c\u4e00\u89c8 \u53e3\u5934\u62a5\u544a\u6458\u8981\u53f7\uff1aS283\u7b2c\u4e00\u4f5c\u8005\uff1a\u9646\u4f69\u534e\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u4efb\u6c5f\u6d9b\u9898\u76ee\uff1aCDT402: A Universal Anti-CD7 Chimeric Antigen Receptor T-Cell Therapy for Patients [&hellip;]","og_url":"https:\/\/moneycompass.com.my\/cn\/\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025eha\uff0c\u901a\u7528\u578bcar-t\u7597\u6cd5\u5f15\u53d1\/","og_site_name":"Money Compass CN","article_published_time":"2025-06-19T07:08:00+00:00","og_image":[{"width":144,"height":108,"url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/","url":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/","name":"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee - Money Compass CN","isPartOf":{"@id":"https:\/\/moneycompass.com.my\/cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage"},"image":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage"},"thumbnailUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg","datePublished":"2025-06-19T07:08:00+00:00","dateModified":"2025-06-19T07:08:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#primaryimage","url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg","contentUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/06\/image_1-0Q2to6.jpeg","width":144,"height":108},{"@type":"BreadcrumbList","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f8%e9%a1%b9%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82025eha%ef%bc%8c%e9%80%9a%e7%94%a8%e5%9e%8bcar-t%e7%96%97%e6%b3%95%e5%bc%95%e5%8f%91\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moneycompass.com.my\/cn\/"},{"@type":"ListItem","position":2,"name":"\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f8\u9879\u6210\u679c\u4eae\u76f82025EHA\uff0c\u901a\u7528\u578bCAR-T\u7597\u6cd5\u5f15\u53d1\u5168\u7403\u77a9\u76ee"}]},{"@type":"WebSite","@id":"https:\/\/moneycompass.com.my\/cn\/#website","url":"https:\/\/moneycompass.com.my\/cn\/","name":"Money Compass CN","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/12648"}],"collection":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/comments?post=12648"}],"version-history":[{"count":0,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/12648\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media\/12649"}],"wp:attachment":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media?parent=12648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/categories?post=12648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/tags?post=12648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}